MakeMyTrip confidentially files DRHP with SEBI for India listing
MakeMyTrip has confidentially filed its draft prospectus with SEBI, BSE and NSE to list its Indian business, with parent and ibibo Group selling equity. Issue size remains undisclosed; proceeds are earmarked for long-term growth, inorganic initiatives and buybacks. The group has traded on Nasdaq since 2010.
MakeMyTrip confidentially filed a DRHP with SEBI, BSE and NSE to list its Indian business, with parent and ibibo Group selling equity. Issue size undisclosed; proceeds to fund long-term growth, inorganic initiatives and buybacks.
Why this matters
The filing confirms earlier signals of a confidential DRHP for an India main-board IPO via offer for sale, with prior reports flagging a potential dual US-India listing of up to $1 billion.
Retail-company signals are accelerating at +862600% QoQ.